pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 5·1 min read
save

GOP Oversight Chair James Comer Targets AMA Billing Codes Over Fraud Concerns

May 5, 2026·read at STAT ↗RegulatoryNeutral

House Oversight Committee Chair James Comer, a Republican from Kentucky, is directing new scrutiny toward the American Medical Association's Current Procedural Terminology (CPT) billing codes, alleging they may be linked to fraud, waste, and abuse.

The move reflects a broader Republican push to tighten controls on health‑care billing practices and curb perceived fraudulent activity within the system.

The report appears in STAT's D.C. Diagnosis newsletter and is available to subscribers of the STAT+ service, which requires a paid subscription for full access.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: A new attack on AMA’s billing codes”

read at STAT ↗
443 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AXSOMELILLY
topics
HepatologyImmunologyMonoclonal AntibodyObesity

related stories

  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT
  • May 5STAT+: Are analysts too quick to gloss over Lilly’s liver case?STAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech